• Latest
  • Trending
Mubadala Capital announces $200 million in Tenvie Therapeutics for Alzheimer’s, Parkinson’s disease therapies

Mubadala Capital announces $200 million in Tenvie Therapeutics for Alzheimer’s, Parkinson’s disease therapies

January 13, 2025
HALA raises $157 million Series B funding to expand fintech’s regional reach

HALA raises $157 million Series B funding to expand fintech’s regional reach

September 15, 2025
UK supports Ethiopian digital economy with £4.6 million AI grant

UK supports Ethiopian digital economy with £4.6 million AI grant

September 15, 2025
Kenya launches Qubit Hub to boost AI innovation

Kenya launches Qubit Hub to boost AI innovation

September 15, 2025
Microsoft and OpenAI strengthen AI partnership with new agreement

Microsoft and OpenAI strengthen AI partnership with new agreement

September 15, 2025
70% of stablecoin users in Africa focus on personal needs – Yellow Card

70% of stablecoin users in Africa focus on personal needs, says Yellow Card

September 15, 2025
Dashen Bank boosts clean energy with solar panel installation across branches

Dashen Bank boosts clean energy with solar panel installation across branches

September 15, 2025
Infinix GT 30 Pro price and availability in Kenya

Infinix GT 30 Pro price and availability in Kenya

September 15, 2025
What you need to know about Nigeria’s first stablecoin, cNGN

What you need to know about Nigeria’s first stablecoin, cNGN

September 15, 2025
Nucleon Security gets €3M to expand its AI cybersecurity across Africa

Nucleon Security gets €3M to expand its AI cybersecurity across Africa

September 15, 2025
Yango Motors brings new mobility to Côte d’Ivoire

Yango Motors brings new mobility to Côte d’Ivoire

September 15, 2025
Your one-stop tech hub! Get the latest updates on AI, cybersecurity, fintech, and emerging technologies.
  • Tech News
    • Africa Tech
    • Global Tech
    • Tech with Pelumy
    • Tech Careers
    • Tech TV
    • General News
    • How To
    • Reviews
  • Cryptocurrency
  • Fintech
  • Startups
  • Ai
No Result
View All Result
  • Tech News
    • Africa Tech
    • Global Tech
    • Tech with Pelumy
    • Tech Careers
    • Tech TV
    • General News
    • How To
    • Reviews
  • Cryptocurrency
  • Fintech
  • Startups
  • Ai
No Result
View All Result
Techpression
No Result
View All Result
Home Business Editors Pick

Mubadala Capital announces $200 million in Tenvie Therapeutics for Alzheimer’s, Parkinson’s disease therapies

Modupeoluwa Olalere by Modupeoluwa Olalere
January 13, 2025
143 9
0
Mubadala Capital announces $200 million in Tenvie Therapeutics for Alzheimer’s, Parkinson’s disease therapies

Mubadala Capital announces $200 million in Tenvie Therapeutics for Alzheimer’s, Parkinson’s disease therapies

471
SHARES
Share on FacebookShare on TwitterWhatsAppTelegram

Mubadala Capital has recently announced a significant investment of $200 million in Tenvie Therapeutics on January 9, 2025. 

Tenvie, which Tony Estrada started, is focused on developing new treatments for diseases that affect the brain and nervous system, which can profoundly impact people’s lives.

Read also: HealthTech Hub Africa launches 2025 program for African health startups

A new hope for patients

Tony Estrada, the founder and chief scientist of Tenvie, expressed his vision by saying, “Tenvie was founded to fundamentally alter the treatment paradigm for neurological diseases and profoundly impact the lives of patients, their families, and caregivers.” 

RelatedPosts

No Content Available

This means that Tenvie aims to change how we approach the treatment of these complex illnesses, making it possible to improve the quality of life for those affected. 

The company is working on innovative therapies that target inflammation and restore brain function, which could lead to better outcomes for patients suffering from conditions like Alzheimer’s disease and Parkinson’s disease.

Support from Mubadala Capital

Mubadala Capital’s investment highlights its commitment to supporting groundbreaking healthcare innovations. Alaa Halawa, who leads Mubadala’s healthcare investments, remarked, “Tenvie’s approach demonstrates a commitment to addressing unmet needs in neurology.”

This funding will enable Tenvie to expand its research and development efforts significantly. With a strong lineup of potential treatments already in the pipeline, Tenvie is well-positioned to make a meaningful difference in biotechnology and help many individuals struggling with neurological disorders. 

Read also: Compass Global’s initiative bridges Africa’s trade gaps, focuses on youth and women entrepreneurs

About Tenvie Therapeutics

Tenvie Therapeutics is a biotechnology company founded to improve patients’ lives with neurological, cardiometabolic, and ophthalmic diseases.

The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lysosomal issues, with a robust pipeline inherited from Denali Therapeutics.

Tenvie is progressing a range of therapeutics aimed at addressing neurological, cardiometabolic, and ophthalmic conditions. Its collection of fully owned, highly brain-penetrant, and precisely designed peripherally restricted small molecules targets three main factors of disease: alleviating inflammation, correcting metabolic dysfunction, and rejuvenating lysosomal function.

Tags: Mubadala CapitalTenvie Therapeutics
Modupeoluwa Olalere

Modupeoluwa Olalere

Modupe is a tech content writer with 3+ years of experience turning complex ideas into clear, engaging stories. She covers innovation, digital trends, and emerging technologies. When she’s not writing, she’s exploring new tools or tracking trends shaping Africa’s tech ecosystem.

No Result
View All Result

Quick Links

  • Tech News
  • Cryptocurrency
  • Fintech
  • Startups
  • Business

Follow Us:

  • facebook
  • instagram
  • Twitter(X)
  • Linkedin
  • YouTube
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 Techpression.com -Techpression Media Limited

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

No Result
View All Result
  • Home
  • Tech News
    • Africa Tech
    • Global Tech
    • Tech with Pelumy
    • Tech Careers
    • Reviews
    • How To
    • General News
  • Cryptocurrency
  • Business
  • Fintech
  • Startups
  • Featured
  • Ai
  • Tech TV

© 2025 Techpression.com -Techpression Media Limited

techpression.com
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.